Validation and Successful Implementation of SCANRDI®
A Rapid Microbiology Method for Testing Sterility of Filterable Drug Products
While rapid microbiological methods (RMM) have been in common use by the food, health, and beauty aid industries for decades, the more highly regulated pharmaceutical industry has been slower to adopt them. The FDA supports RMMs for drug testing, as long as these alternative methods are validated to demonstrate their equivalency to the compendial methods. Compounded sterile preparations, with their inherently short shelf lives, are a perfect fit for sterility testing by rapid microbiology methods.
This case study outlines the qualification and validation process conducted at Atlas Analytical to sterility test and release customers’ compounded drug products. Atlas Analytical is a contract testing laboratory which supports sterile compounding pharmacies with cGMP compliant microbiological and analytical testing.
Download the Case Study
Learn how Atlas Analytical demonstrated that the SCANRDI® technology is qualified for determining the sterility of test samples.
Complete the form below to access the case study, which will be sent directly to your email after submission. By providing your information, you agree to receive additional emails from bioMérieux about sterility testing.
To find out more about the management of your personal data and to exercise your rights, see our privacy policy.